Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis

Clinical Infectious Diseases

Volumn 62, Issue 9, 2016, Pages 1111-1118

  Hammarlund, Erika ^a   Thomas, Archana ^a   Poore, Elizabeth A ^b   Amanna, Ian J ^b   Rynko, Abby E ^a   Mori, Motomi ^c   Chen, Zunqiu ^c   Slifka, Mark K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Najit Technologies   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cross sectional analysis; diphtheria; immunological memory; Tetanus

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA TETANUS VACCINE; DIPHTHERIA TOXIN; TETANUS ANTIBODY; TETANUS TOXIN; BACTERIUM ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CROSS-SECTIONAL STUDY; DIPHTHERIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERD IMMUNITY; HUMAN; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; TETANUS; VACCINATION; ANTIBODY PRODUCTION; BLOOD; EVALUATION STUDY; HALF LIFE TIME; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; SECONDARY IMMUNIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CROSS-SECTIONAL STUDIES; DIPHTHERIA TOXIN; DIPHTHERIA-TETANUS VACCINE; FEMALE; HALF-LIFE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; TETANUS TOXIN; YOUNG ADULT;

EID: 84966546947     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw066     Document Type: Article

References (43)

1. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007; 298:2155-63.
2. Wassilak SG, Roper MH, Kretsinger K, Orenstein WA. Tetanus toxoid. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Saunders Elsevier, 2008.
3. Vaccine Safety Committee. Diphtheria and tetanus toxoids. Adverse events associated with childhood vaccines: evidence bearing on causality. In: Stratton KR, Howe CJ, Johnston RB, eds. Research strategies for assessing adverse effects associated with vaccines. Washington, DC: National Academy Press, 1994:67-117.
4. National Communicable Disease Center. Recommendation of Public Health Service Advisory Committee on Immunization Practices: diphtheria, tetanus, and pertussis vaccines: tetanus prophylaxis in wound management. MMWR Morb Mortal Wkly Rep 1966; 15:416-8.
5. Peebles TC, Levine L, Eldred MC, Edsall G. Tetanus-toxoid emergency boosters: a reappraisal. N Engl J Med 1969; 280:575-81.
6. Bonsignori M, Moody MA, Parks RJ, et al. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. J Immunol 2009; 183:2708-17.
7. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007; 357:1903-15.
8. Centers for Disease Control and Prevention. Immunization schedules. Available at: http://www.cdc.gov/vaccines/schedules/. Accessed 6 January 2016.
9. Public Health Agency of Canada. Canadian immunization guide. Available at: http://www.phac-aspc.gc.ca/publicat/cig-gci/p03-02-eng.php. Accessed 6 January 2016.
10. Wagner KS, White JM, Andrews NJ, et al. Immunity to tetanus and diphtheria in the UK in 2009. Vaccine 2012; 30:7111-7.
11. The National Board of Health andWelfare. Regulations for the prevention of diphtheria and tetanus (SOSFS 1990-10-21,ISSN: 0346-6000) [in Swedish]. Stockholm, Sweden: Socialstyrelsen, 1990.
12. The National Board of Health and Welfare. Recommendations for the prevention of diphtheria and tetanus in adults. (2009-130-5) [in Swedish], 2009. Available at: https://www.folkhalsomyndigheten.se/pagefiles/20442/rekommendationer-forprofylax-till-vuxna-mot-difteri-och-stelkramp-2009-130-5.pdf. Accessed 17 February 2016.
13. Siegrist CA. New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria [in French]. Rev Med Suisse 2012; 8:125-8.
14. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nature Medicine 2003; 9:1131-7.
15. Rosskopf U, Noeske K, Werner E. Efficacy demonstration of tetanus vaccines by double antigen ELISA. Pharmeuropa Bio 2005:31-52.
16. Usuwanthim K, Pootong A, Chaisri U, et al. Murine monoclonal antibodies neutralizing the cytotoxic activity of diphtheria toxin. Asian Pac J Allergy Immunol 2008; 26:47-55.
17. Vitek CR, Wharton M. Diphtheria toxoid. In: Plotkin SA, OrensteinWA, Offit PA, eds. Vaccines. Philadelphia: Saunders Elsevier, 2008.
18. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332:761-6.
19. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002; 136:660-6.
20. Kruszon-Moran DM, McQuillan GM, Chu SY. Tetanus and diphtheria immunity among females in the United States: are recommendations being followed? Am J Obstet Gynecol 2004; 190:1070-6.
21. Wolters KL, Dehmel H. Abschliessende untersuchungen uber die Tetanus Prophylaxe durch active Immunisierung. Zeitschrift fur Hyeitschrift 1942; 124:326-32.
22. Scheibel I. The uses and results of active tetanus immunization. BullWorld Health Organ 1955; 13:381-94.
23. McComb JA. The prophylactic dose of homologous tetanus antitoxin. N Engl J Med 1964; 270:175-8.
24. Pappenheimer AM Jr. The Schick test, 1913-1958. Int Arch Allergy Appl Immunol 1958; 12:35-41.
25. Ipsen J. Circulating antitoxin at the onset of diphtheria in 425 patients. J Immunol 1946; 54:325-47.
26. Bjorkholm B, Bottiger M, Christenson B, Hagberg L. Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand J Infect Dis 1986; 18:235-9.
27. Garman L, Vineyard AJ, Crowe SR, et al. Humoral responses to independent vaccinations are correlated in healthy boosted adults. Vaccine 2014; 32:5624-31.
28. Olander RM, Auranen K, Harkanen T, Leino T. High tetanus and diphtheria antitoxin concentrations in Finnish adults-time for new booster recommendations? Vaccine 2009; 27:5295-8.
29. Centers for Disease Control and Prevention. Notifiable diseases and mortality tables. MMWR Morb Mortal Wkly Rep 2013; 62:ND-86.
30. Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus surveillance-United States, 1998-2000. MMWR Surveill Summ 2003; 52:1-8.
31. Centers for Disease Control and Prevention. Tetanus Surveillance-United States, 1995-1997. MMWR Morb Mortal Wkly Rep 1998; 47(SS-2):1-13.
32. Gardner P. Issues related to the decennial tetanus-diphtheria toxoid booster recommendations in adults. Infect Dis Clin North Am 2001; 15:143-53, ix-x.
33. Centers for Disease Control and Prevention. Tetanus surveillance-United States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011; 60:365-9.
34. Balestra DJ, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? a cost-effectiveness analysis. J Gen Intern Med 1993; 8:405-12.
35. LaForce FM. Routine tetanus immunizations for adults: once is enough. J Gen Intern Med 1993; 8:459-60.
36. WHO. Tetanus vaccine WHO position paper. Wkly Epidemiol Rec 2006; 20:198-208.
37. Golaz A, Hardy IR, Strebel P, et al. Epidemic diphtheria in the Newly Independent States of the former Soviet Union: implications for diphtheria control in the United States. J Infect Dis 2000; 181(suppl 1):S237-43.
38. Galazka A. Implications of the diphtheria epidemic in the former Soviet Union for immunization programs. J Infect Dis 2000; 181(suppl 1):S244-8.
39. Dittmann S, Wharton M, Vitek C, et al. Successful control of epidemic diphtheria in the states of the former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 181(suppl 1):S10-22.
40. Centers for Disease Control and Prevention. Diphtheria: epidemiology and prevention of vaccine-preventable diseases. The pink book: course textbook. 13th ed. 2015. Available at: http://www.cdc.gov/vaccines/pubs/pinkbook/dip. html. Accessed 8 January 2016.
41. Williams WW, Lu PJ, O'Halloran A, et al. Vaccination coverage among adults, excluding influenza vaccination-United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64:95-102.
42. Centers for Disease Control and Prevention. Adult vaccination coverage-United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 61:66-72.
43. Centers for Disease Control and Prevention. CDC vaccine price list. Available at: http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/pricelist/index.html#f1. Accessed 6 January 2016.